Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group

被引:17
作者
Kwon, Sung Wook [2 ]
Kang, Seung Kyu [1 ]
Lee, Jae Hong [2 ]
Bok, Joo Hwan [1 ]
Kim, Chi Hyun [1 ]
Rhee, Sang Dal [1 ]
Jung, Won Hoon [1 ]
Kim, Hee Youn [1 ]
Bae, Myung Ae [1 ]
Song, Jin Sook [1 ]
Ha, Duck Chan [2 ]
Cheon, Hyae Gyoung [1 ]
Kim, Ki Young [1 ]
Ahn, Jin Hee [1 ]
机构
[1] Korea Res Inst Chem Technol, Drug Discovery Div, Taejon 305600, South Korea
[2] Korea Univ, Dept Chem, Seoul 136701, South Korea
关键词
Diabetes; 11beta-HSD1; Thiazolidine; Adamantyl; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; METABOLIC SYNDROME; VISCERAL OBESITY; TYPE-1; MICE; HYPERGLYCEMIA; DRUGS;
D O I
10.1016/j.bmcl.2010.10.123
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of thiazolidine derivatives with an adamantyl group was synthesized and evaluated for their ability to inhibit 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1). Our initial compound 5a showed a weak inhibitory activity. Significant improvements in potency were achieved by substituent modification. The potent compound 8g (E) showed good in vitro inhibitory activity toward human 11 beta-HSD1, selectivity toward 11 beta-HSD2, metabolic stability, pharmacokinetic, and safety profile. Furthermore, this compound significantly inhibited 11 beta-HSD1 activity in rat and monkey models, and showed improved glycemic control in KKAy mice. (c) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:435 / 439
页数:5
相关论文
共 15 条
  • [1] Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs.: Discovery of potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1
    Barf, T
    Vallgårda, J
    Emond, R
    Häggström, C
    Kurz, G
    Nygren, A
    Larwood, V
    Mosialou, E
    Axelsson, K
    Olsson, R
    Engblom, L
    Edling, N
    Rönquist-Nii, Y
    Öhman, B
    Alberts, P
    Abrahmsén, L
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) : 3813 - 3815
  • [2] A Convergent Process for the Preparation of Adamantane 11-β-HSD-1 Inhibitors
    Becker, Calvin L.
    Engstrom, Kenneth M.
    Kerdesky, Francis A.
    Tolle, John C.
    Wagaw, Seble H.
    Wang, Weifeng
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2008, 12 (06) : 1114 - 1118
  • [3] The development and SAR of pyrrolidine carboxamide 11β-HSD1 inhibitors
    Cheng, Hengmiao
    Hoffman, Jacqui
    Le, Phuong
    Nair, Sajiv K.
    Cripps, Stephan
    Matthews, Jean
    Smith, Christopher
    Yang, Michele
    Kupchinsky, Stan
    Dress, Klaus
    Edwards, Martin
    Cole, Bridget
    Walters, Evan
    Loh, Christine
    Ermolieff, Jacques
    Fanjul, Andrea
    Bhat, Ganesh B.
    Herrera, Jocelyn
    Pauly, Tom
    Hosea, Natilie
    Paderes, Genevieve
    Rejto, Paul
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) : 2897 - 2902
  • [4] 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development
    Ge, R.
    Huang, Y.
    Liang, G.
    Li, X.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2010, 17 (05) : 412 - 422
  • [5] Crystallization Induced Dynamic Resolution of Ethyl Thiazolidine-2-Carboxylate
    Kang, Seung Kyu
    Park, Woul Seong
    Thopate, T. S.
    Ahn, Jin Hee
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2010, 31 (09): : 2709 - 2711
  • [6] 11β-hydroxysteroid dehydrogenase type 2 is expressed in the human kidney glomerulus
    Kataoka, S
    Kudo, A
    Hirano, H
    Kawakami, H
    Kawano, T
    Higashihara, E
    Tanaka, H
    Delarue, F
    Sraer, JD
    Mune, T
    Krozowski, ZS
    Yan, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) : 877 - 882
  • [7] 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress
    Kotelevtsev, Y
    Holmes, MC
    Burchell, A
    Houston, PM
    Schmoll, D
    Jamieson, P
    Best, R
    Brown, R
    Edwards, CRW
    Seckl, JR
    Mullins, JJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14924 - 14929
  • [8] 11-BETA-HYDROXYSTEROID DEHYDROGENASE AND THE SHORT-CHAIN ALCOHOL-DEHYDROGENASE (SCAD) SUPERFAMILY
    KROZOWSKI, Z
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1992, 84 (1-2) : C25 - C31
  • [9] A transgenic model of visceral obesity and the metabolic syndrome
    Masuzaki, H
    Paterson, J
    Shinyama, H
    Morton, NM
    Mullins, JJ
    Seckl, JR
    Flier, JS
    [J]. SCIENCE, 2001, 294 (5549) : 2166 - 2170
  • [10] Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice
    Morton, NM
    Paterson, JM
    Masuzaki, H
    Holmes, MC
    Staels, B
    Fievet, C
    Walker, BR
    Flier, JS
    Mullins, JJ
    Seckl, JR
    [J]. DIABETES, 2004, 53 (04) : 931 - 938